Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: 18 - The Real Truth

Marriott International Says Travel Demand Stays Strong Despite Middle East RevPAR Drag

Marriott International (NASDAQ:MAR) Chief Financial Officer Jen Mason said travel demand remains broadly healthy, with leisure and group travel showing strength, while the Middle East remains the company’s primary near-term headwind. Speaking at a Morgan Stanley investor conference, Mason, who rece

Jade Biosciences’ JADE101 Delivers Deep IgA Cuts, Clearing Path for Kidney Trials

Jade Biosciences (NASDAQ:JBIO) said interim results from a Phase 1 healthy volunteer study of JADE101 showed rapid and durable reductions in serum IgA, supporting the company’s plan to advance the antibody into patient studies for IgA nephropathy. Chief Executive Officer Tom Frohlich said JADE101,

Hewlett Packard Enterprise Q2 Earnings Call Highlights

Hewlett Packard Enterprise (NYSE:HPE) reported what executives described as a record fiscal 2026 second quarter, with revenue and earnings exceeding the company’s outlook and management raising its full-year financial targets on stronger demand across networking, cloud and AI. President and Chief E

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Credo Technology Group Q4 Earnings Call Highlights

Credo Technology Group (NASDAQ:CRDO) reported record fiscal fourth-quarter and full-year results, with management pointing to strong demand for artificial intelligence data center connectivity and forecasting another year of rapid growth. Chief Executive Officer Bill Brennan said fiscal 2026 was “a

Edap Tms Unveils FocalTherics Pivot, Targets 40% Growth on HIFU Expansion

Edap Tms (NASDAQ:EDAP) used its 2026 FocalTherics Investor Day to outline its shift toward becoming a “high-growth, pure-play robotic focal therapy company,” with management emphasizing the company’s Focal One robotic high-intensity focused ultrasound, or HIFU, platform for prostate cancer and futur

Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance

Braze Inc. is on track for price recovery in 2026 as results surpass expectation and management signals confidence with share repurchases.

Science Applications International Q1 Earnings Call Highlights

Science Applications International (NASDAQ:SAIC) reported a stronger-than-expected start to fiscal 2027, with executives pointing to record margins, steady cash generation and early signs of improvement in federal spending activity while maintaining a cautious stance on the full year. Chief Executi

inkl

Read news from The Economist, FT, and more,
with one subscription

Corbus Pharmaceuticals Targets HPV-Linked Head and Neck Cancer With CRB-701 Study

Corbus Pharmaceuticals Targets HPV-Linked Head and Neck Cancer With CRB-701 Study

Corbus Pharmaceuticals (NASDAQ:CRBP) executives and oncology specialists used an ASCO-linked discussion to outline the rationale for focusing the company’s CRB-701 program on recurrent or metastatic oropharyngeal head and neck cancer, particularly in patients whose disease is associated with human p

Drax Group Pauses Buyback as £561M Bluefield Solar Deal Boosts UK Renewables

Drax Group (LON:DRX) Chief Executive Will Gardiner said the company’s recommended all-cash offer to acquire Bluefield Solar Income Fund would significantly expand Drax’s U.K. renewables business and broaden its generation portfolio, while prompting a pause in its current share buyback program pendin

Sirius Real Estate H2 Earnings Call Highlights

Sirius Real Estate (LON:SRE) reported higher full-year funds from operations, rental income and dividends for the period ended March 31, 2026, as management said acquisitions and like-for-like rent roll growth offset macroeconomic pressure in the U.K. and Europe. Group Chief Executive Officer Andre

NVIDIA Says “Useful AI Has Arrived” as Vera Rubin Enters Full Production

NVIDIA (NASDAQ:NVDA) Founder and CEO Jensen Huang used a keynote in Taiwan to outline the company’s next phase of growth around agentic AI, AI factories, new data center systems, enterprise software tools, personal computers and robotics. Speaking at GTC Taiwan, Huang repeatedly credited Taiwan’s s

Legend Biotech Conference Spotlights CARVYKTI’s Curative Potential, Earlier Use

Legend Biotech (NASDAQ:LEGN) used an investor and analyst event to highlight long-term data and physician perspectives supporting broader use of CARVYKTI, its BCMA-directed CAR T-cell therapy for multiple myeloma developed, manufactured and co-promoted with Johnson & Johnson. Chief Executive Of

Cango Q1 Earnings Call Highlights

Cango (NYSE:CANG) reported first-quarter 2026 revenue of approximately $102 million, driven primarily by its Bitcoin mining business, as management said the company is prioritizing cost discipline and cash flow resilience over hash rate scale during a period of industry adjustment. Chief Executive

GRAIL’s Galleri Test Cuts Stage 4 Cancer Diagnoses in Study Despite Missed Endpoint

GRAIL (NASDAQ:GRAL) said new data presented at the American Society of Clinical Oncology annual meeting showed its Galleri multi-cancer early detection blood test can identify more cancers through screening and reduce stage 4 diagnoses, though the company confirmed that a primary endpoint in its lar

Get all your
news in one place.

100's of premium titles.
One news app.

Phillips Edison & Company Says Grocery-Anchored Demand Is Strong, Deals Active

Phillips Edison & Company, Inc. (NASDAQ:PECO) executives said demand for grocery-anchored shopping centers remains strong following the company’s meetings at ICSC Las Vegas, citing robust retailer expansion plans, limited supply and continued opportunities for acquisitions. During an ICSC recap

Oculis Shelves FDA Filing After Phase 3 DME Trials Miss Key Vision Goals

Oculis (NASDAQ:OCS) said its two Phase 3 DIAMOND trials of OCS-01 in diabetic macular edema did not meet their primary endpoints, and the company does not currently plan to pursue a U.S. Food and Drug Administration filing for the drug candidate in that indication. Chief Executive Officer Riad Sher

OceanFirst Financial Shareholders Approve All Proposals as Flushing Deal Shapes Growth

OceanFirst Financial (NASDAQ:OCFC) shareholders approved all proposals presented at the company’s 2026 annual meeting, including the election of 13 directors, an advisory vote on executive compensation, the company’s 2026 Stock Incentive Plan and the ratification of Deloitte & Touche LLP as inde

Nextpower Bets on Battery Storage, AI Data Centers With $365M Prevalon Deal

Nextpower (NASDAQ:NXT) said it has entered into a definitive agreement to acquire Prevalon Energy, a utility-scale battery energy storage systems provider, in a transaction the company said would expand its platform beyond solar into storage, controls, software and lifecycle services. Founder and C

Get all your
news in one place.

100's of premium titles.
One news app.

Glencore AGM Spotlights Copper Growth, Buybacks as Safety and Labor Concerns Loom

Glencore (LON:GLEN) executives used the company’s annual general meeting to emphasize safety, copper growth plans, shareholder returns and the role of its marketing business, while facing shareholder and stakeholder questions on labor relations, mine closures and tailings safety. Kalidas Madhavpedd

NXP Semiconductors Turns More Optimistic as Auto Demand and Data Center Sales Improve

NXP Semiconductors (NASDAQ:NXPI) is seeing a more constructive demand environment than it did several months ago, particularly in automotive, Executive Vice President of Investor Relations Jeff Palmer said at TD Cowen’s Technology, Media & Telecom Conference. Speaking with TD Cowen semiconducto

Match Group Says Tinder Turnaround Is Gaining Traction as Hinge Growth Stays Strong

Match Group (NASDAQ:MTCH) Chief Financial Officer Steven Bailey said Tinder is showing signs that recent product and marketing changes are beginning to translate into stronger user trends and better financial metrics. Speaking at an investor conference, Bailey said the company’s thesis for improvin

MannKind Wins FDA Approval for Afrezza in Children, Opening Pediatric Diabetes Market

MannKind (NASDAQ:MNKD) said the U.S. Food and Drug Administration has approved Afrezza for pediatric patients with diabetes ages 6 and older, expanding the inhaled mealtime insulin’s label into children and adolescents. Chief Executive Officer Michael Castagna called the decision “a truly historic

Meta Platforms Investors Reject Proposals as Zuckerberg Bets Big on AI

Meta Platforms (NASDAQ:META) shareholders rejected a slate of outside investor proposals at the company’s 2026 annual meeting, while Chairman and CEO Mark Zuckerberg outlined what he described as four major opportunities tied to artificial intelligence: improving Meta’s core apps and advertising, pe

Microchip Technology Says Inventory Slump Is Nearing End as Data Center Wins Build

Microchip Technology (NASDAQ:MCHP) executives said the company is nearing the end of a prolonged inventory correction while positioning for growth tied to data centers, aerospace and defense, automotive systems and industrial markets. Speaking at TD Cowen’s 54th annual TMT conference, President and

Marathon Digital Bets Its Bitcoin Mining Power Assets Can Fuel AI Data Center Growth

Marathon Digital (NASDAQ:MARA) Chairman and Chief Executive Officer Fred Thiel said the company’s push into AI and high-performance computing infrastructure has been a multiyear process built on its experience aggregating low-cost power and data center capacity for bitcoin mining. Speaking at TD Co

1 … 17 18 19 20

People

Mark Zuckerberg

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Johnson & Johnson (

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Prostate Cancer

Places

416,554 stories

148,931 stories

The United States

the Middle East

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play